These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 20088280)

  • 1. Top 20 pharmaceutical companies. Ranked by U.S. sales, October 2008 to September 2009.
    Mod Healthc; 2010 Jan; 40(1):31. PubMed ID: 20088280
    [No Abstract]   [Full Text] [Related]  

  • 2. Top 20 pharmaceutical companies. Ranked by U.S. sales, October 2007 to September 2008.
    Mod Healthc; 2009 Jan; 39(1):32. PubMed ID: 19226860
    [No Abstract]   [Full Text] [Related]  

  • 3. By the numbers. Top 20 pharmaceutical companies, ranked by U.S. sales, October 2004 to September 2005.
    Mod Healthc; 2006 Jan; 36(1):30. PubMed ID: 16447814
    [No Abstract]   [Full Text] [Related]  

  • 4. By the numbers. Top 20 pharmaceutical companies ranked by U.S. sales, October 2006 to September 2007.
    Mod Healthc; 2008 Jan; 38(1):31. PubMed ID: 18271198
    [No Abstract]   [Full Text] [Related]  

  • 5. By the numbers. Top 20 pharmaceutical companies ranked by U.S. sales, November 2003 to October 2004.
    Moon S
    Mod Healthc; 2005 Jan; 35(1):32. PubMed ID: 15693520
    [No Abstract]   [Full Text] [Related]  

  • 6. Top 20 pharmaceutical companies. Ranked by U.S. sales, December 2005 to November 2006.
    Mod Healthc; 2007 Jan; 37(2):33. PubMed ID: 17243346
    [No Abstract]   [Full Text] [Related]  

  • 7. By the numbers. Top 20 pharmaceutical companies. Ranked by U.S. sales, April 2003 through March 2004.
    Moon S
    Mod Healthc; 2004 Aug; 34(33):40. PubMed ID: 15356990
    [No Abstract]   [Full Text] [Related]  

  • 8. Largest pharmaceutical companies. Ranked by U.S. retail sales, December 2009 to November 2010.
    Mod Healthc; 2011 Jan; 41(1):33. PubMed ID: 21322350
    [No Abstract]   [Full Text] [Related]  

  • 9. Largest pharmaceutical companies: ranked by U.S. retail sales, December 2011.
    Mod Healthc; 2012 May; 42(21):34. PubMed ID: 22745970
    [No Abstract]   [Full Text] [Related]  

  • 10. By the numbers. Top 20 pharmaceutical companies.
    Mod Healthc; 2003 Aug; 33(33):33. PubMed ID: 12964487
    [No Abstract]   [Full Text] [Related]  

  • 11. Most profitable U.S. drug and biologic companies. Ranked by 2013 profit margin.
    Mod Healthc; 2014 Dec; Suppl():30. PubMed ID: 25831880
    [No Abstract]   [Full Text] [Related]  

  • 12. Most profitable U.S. health insurance, medical device, and drug and biologic companies.
    Mod Healthc; 2013 Jul; 43(30):38. PubMed ID: 24010242
    [No Abstract]   [Full Text] [Related]  

  • 13. Fortune 1,000. Ranked within industries. 8. Chemicals.
    Fortune; 2004 Apr; 149(7):F46. PubMed ID: 15077536
    [No Abstract]   [Full Text] [Related]  

  • 14. Fortune 1,000 ranked within industries. 48. Pharmaceuticals.
    Fortune; 2004 Apr; 149(7):F59-F60. PubMed ID: 15077541
    [No Abstract]   [Full Text] [Related]  

  • 15. Blood brothers. Alliances between biotechnology and pharmaceutical companies in the U.S.
    Dibner MD
    Biotechnology (N Y); 1993 Oct; 11(10):1120, 1122-3. PubMed ID: 7764092
    [No Abstract]   [Full Text] [Related]  

  • 16. Barrier to trade or barrier to profit? Why Australia's Pharmaceutical Benefits Scheme worries U.S. drug companies.
    Hamilton C; Lokuge B; Denniss R
    Yale J Health Policy Law Ethics; 2004; 4(2):373-85. PubMed ID: 15536919
    [No Abstract]   [Full Text] [Related]  

  • 17. Effective executive management in the pharmaceutical industry.
    Tran H; Kleiner BH
    J Health Care Finance; 2005; 32(1):8-15. PubMed ID: 18972973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fortune 1,000 ranked within industries. Pharmaceuticals.
    Fortune; 2005 Apr; 151(8):F61-2. PubMed ID: 15852689
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmaceutical marketing in a new age. Effective campaigns still need to focus on what customers want.
    Rao SK
    Mark Health Serv; 2002; 22(1):6-12. PubMed ID: 11881547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The economic fundamentals of the U.S. pharmaceutical market.
    Lybecker KM
    Manag Care; 2004 Jun; 13(6 Suppl):7-9; discussion 12-3, 41-2. PubMed ID: 15303519
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.